Epr Studies of Intermolecular Interactions and Competitive Binding of Drugs in a Drug-Bsa Binding Model
Loading...
Files
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Open Access Color
HYBRID
Green Open Access
Yes
OpenAIRE Downloads
OpenAIRE Views
Publicly Funded
No
Abstract
Understanding intermolecular interactions between drugs and proteins is very important in drug delivery studies. Here, we studied different binding interactions between salicylic acid and bovine serum albumin (BSA) using electron paramagnetic resonance (EPR) spectroscopy. Salicylic acid was labeled with a stable radical (spin label) in order to monitor its mobilized (free) or immobilized (bound to BSA) states. In addition to spin labeled salicylic acid (SL-salicylic acid), its derivatives including SL-benzoic acid, SL-phenol, SL-benzene, SL-cyclohexane and SL-hexane were synthesized to reveal the effects of various drug binding interactions. EPR results of these SL-molecules showed that hydrophobic interaction is the main driving force. Whereas each of the two functional groups (-COOH and -OH) on the benzene ring has a minute but detectable effect on the drug-protein complex formation. In order to investigate the effect of electrostatic interaction on drug binding, cationic BSA (cBSA) was synthesized, altering the negative net charge of BSA to positive. The salicylic acid loading capacity of cBSA is significantly higher compared to that of BSA, indicating the importance of electrostatic interaction in drug binding. Moreover, the competitive binding properties of salicylic acid, ibuprofen and aspirin to BSA were studied. The combined EPR results of SL-salicylic acid/ibuprofen and SL-ibuprofen/salicylic acid showed that ibuprofen is able to replace up to ∼83% of bound SL-salicylic acid, and salicylic acid can replace only ∼14% of the bound SL-ibuprofen. This indicates that ∼97% of all salicylic acid and ibuprofen binding sites are shared. On the other hand, aspirin replaces only ∼23% of bound SL-salicylic acid, and salicylic acid replaces ∼50% of bound SL-aspirin, indicating that ∼73% of all salicylic acid and aspirin binding sites are shared. These results show that EPR spectroscopy in combination with the spin labeling technique is a very powerful method to investigate drug binding dynamics in detail.
Description
Keywords
Bovine serum albumin, Electron paramagnetic resonance, Drug delivery, Sspin labeling, Binding Sites, Aspirin, Anti-Inflammatory Agents, Non-Steroidal, Electron Spin Resonance Spectroscopy, Ibuprofen, Serum Albumin, Bovine, Binding, Competitive, Bovine serum albumin, Sspin labeling, Anti-Infective Agents, Pharmaceutical Preparations, Drug delivery, Spin Labels, Electron paramagnetic resonance, Salicylic Acid, Protein Binding
Fields of Science
0301 basic medicine, 0303 health sciences, 03 medical and health sciences
Citation
Akdoğan, Y., Emrullahoğlu, M., Tatlıdil, D., Üçüncü, M., and Çakan Akdoğan, G. (2016). EPR studies of intermolecular interactions and competitive binding of drugs in a drug-BSA binding model. Physical Chemistry Chemical Physics, 18(32), 22531-22539. doi:10.1039/c6cp04137j
WoS Q
Scopus Q

OpenCitations Citation Count
32
Volume
18
Issue
32
Start Page
22531
End Page
22539
Collections
Materials Science and Engineering / Malzeme Bilimi ve Mühendisliği
Chemistry / Kimya
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Chemistry / Kimya
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
PlumX Metrics
Citations
CrossRef : 32
Scopus : 36
PubMed : 10
Captures
Mendeley Readers : 50
SCOPUS™ Citations
36
checked on Apr 28, 2026
Web of Science™ Citations
33
checked on Apr 28, 2026
Page Views
1401
checked on Apr 28, 2026
Downloads
452
checked on Apr 28, 2026
Google Scholar™


